五洲医疗
(301234)
| 流通市值：19.67亿 | | | 总市值：33.29亿 |
| 流通股本：4017.06万 | | | 总股本：6800.00万 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 100,616,784.24 | 458,282,116.04 | 345,417,868.3 | 216,919,129.78 |
| 营业总成本 | 95,348,895.49 | 441,702,032.61 | 328,356,715.98 | 207,769,077.17 |
| 其他经营收益 | | | | |
| 营业利润 | 9,250,544.23 | 23,521,219.29 | 23,479,459.16 | 13,669,250.36 |
| 利润总额 | 9,185,078.33 | 22,893,216.81 | 23,049,571.5 | 13,265,860.76 |
| 净利润 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 555,285,000.94 | 573,742,416.04 | 561,271,065.11 | 540,248,486.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 298,691,303.97 | 295,295,748.28 | 306,227,243.18 | 313,213,280.27 |
| 资产总计 | 853,976,304.91 | 869,038,164.32 | 867,498,308.29 | 853,461,766.5 |
| 流动负债: | | | | |
| 流动负债合计 | 68,763,360.42 | 91,508,518.06 | 85,749,971.22 | 78,947,172.28 |
| 非流动负债: | | | | |
| 非流动负债合计 | 16,143,599.67 | 16,511,282.89 | 21,113,606.12 | 21,874,122.57 |
| 负债合计 | 84,906,960.09 | 108,019,800.95 | 106,863,577.34 | 100,821,294.85 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 769,069,344.82 | 761,018,363.37 | 760,634,730.95 | 752,640,471.65 |
| 股东权益合计 | 769,069,344.82 | 761,018,363.37 | 760,634,730.95 | 752,640,471.65 |
| 负债和股东权益合计 | 853,976,304.91 | 869,038,164.32 | 867,498,308.29 | 853,461,766.5 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 114,039,867.26 | 530,168,112.73 | 405,093,568.52 | 272,535,512.02 |
| 经营活动现金流出小计 | 114,855,626.83 | 456,783,203.04 | 336,017,275.03 | 222,524,260.67 |
| 经营活动产生的现金流量净额 | -815,759.57 | 73,384,909.69 | 69,076,293.49 | 50,011,251.35 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 241,060,871.23 | 1,128,736,994.16 | 853,948,042.86 | 437,201,838.79 |
| 投资活动现金流出小计 | 280,901,790 | 1,257,176,292.99 | 931,432,771.04 | 518,031,830.24 |
| 投资活动产生的现金流量净额 | -39,840,918.77 | -128,439,298.83 | -77,484,728.18 | -80,829,991.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | - | 20,988,907.54 | 20,571,047.54 | 19,190,758.04 |
| 筹资活动产生的现金流量净额 | - | -20,988,907.54 | -20,571,047.54 | -19,190,758.04 |
| 汇率变动对现金及现金等价物的影响 | -1,048,093.84 | 806,486.26 | 1,150,342.02 | 1,122,970 |
| 现金及现金等价物净增加额 | -41,704,772.18 | -75,236,810.42 | -27,829,140.21 | -48,886,528.14 |
| 期末现金及现金等价物余额 | 36,470,539.93 | 78,175,312.11 | 125,582,982.32 | 104,525,594.39 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -75,236,810.42 | - | -48,886,528.14 |